ישראל -
עברית -
Ministry of Health
devices for reconstitution, transfer and administration of drugs in a closed system
גאמידה בע"מ - רופא - העברת נוזלים ישירה במערכת סגורה, למניעת חדירת אוויר למערכת ובריחת נוזלים מהמערכת
ישראל -
עברית -
Ministry of Health
bd nexiva closed iv catheter system
ע. לפידות פרמצויטיקלס בע"מ - אחות - אי.וי.קטטר
ישראל -
עברית -
Ministry of Health
tevadaptor - closed drug reconstitution system
teva medical ltd. - migada - אחות - see attached document : us fda 510(k) k051669 approved indications for use
ישראל -
עברית -
Ministry of Health
equashield - closed system transfer device (cstd)
equashield medical ltd - אחות - the equashield™ drug reconstitution and transfer system is a contained system to be used by pharmacists or other health care professionals to prepare drugs, including cytotoxic drugs, for intravenous infusion or injection
ישראל -
עברית -
Ministry of Health
לפונקס 100 מ"ג טבליות
novartis pharma services ag - clozapine 100 mg - tablets - diazepines, oxazepines, thiazepines and oxepines - for treatment in resistant schizoprenic patients who are non-responsive to, or intolerant to classical neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for diath.
ישראל -
עברית -
Ministry of Health
ct closesure
dolphin medical ltd. - רופא - ציוד ואביזרים ללפארסקופיה התומכים בסגירת פצעים ומונעים היווצרות הרניות
ישראל -
עברית -
Ministry of Health
אזרגה
novartis israel ltd - brinzolamide; timolol as maleate - תרחיף לעין - brinzolamide 10 mg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intra-ocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction.
ישראל -
עברית -
Ministry of Health
קפרה 250 מג
cts ltd - levetiracetam - טבליות מצופות פילם - levetiracetam 250 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
ישראל -
עברית -
Ministry of Health
קפרה 500 מג
cts ltd - levetiracetam - טבליות מצופות פילם - levetiracetam 500 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
ישראל -
עברית -
Ministry of Health
קפרה 1000 מג
cts ltd - levetiracetam - טבליות מצופות פילם - levetiracetam 1000 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.